Site içinde arama yapın

KUMUD SINGH bir ses eklendi Health
2026-04-08 09:52:44

Ad5-nCoV Vaccine Market Growth & CAGR 12.5% Forecast
According to a newly published market research report by 24LifeSciences, the global Ad5-nCoV vaccine market was valued at USD 1.2 billion in 2024 and is projected to reach USD 2.8 billion by 2032, growing at a compound annual growth rate (CAGR) of 12.5% during the forecast period 2025-2032. Ad5-nCoV, developed by CanSino Biologics, is a recombinant adenovirus type-5 vectored COVID-19 vaccine...

0 Yorumlar 0 hisse senetleri 53 Views 0 önizleme

Please log in to like, share and comment!
KUMUD SINGH bir ses eklendi Health
2026-04-08 09:53:28

Ad5-nCoV Vaccine Market Growth & CAGR 12.5% Forecast
According to a newly published market research report by 24LifeSciences, the global Ad5-nCoV vaccine market was valued at USD 1.2 billion in 2024 and is projected to reach USD 2.8 billion by 2032, growing at a compound annual growth rate (CAGR) of 12.5% during the forecast period 2025-2032. Ad5-nCoV, developed by CanSino Biologics, is a recombinant adenovirus type-5 vectored COVID-19 vaccine...

0 Yorumlar 0 hisse senetleri 43 Views 0 önizleme

Please log in to like, share and comment!
Mikel Watson bir ses eklendi Other
2026-02-27 12:42:57

Human Papillomavirus Vaccine (HPV) Market Valuation to Touch US$ 7.71 Billion by 2034
The Human Papillomavirus (HPV) Vaccine is formulated using virus-like particles that mimic the outer protein structure of the virus without containing its genetic material. This design ensures strong immunogenicity while maintaining a high safety profile. By targeting specific high-risk and low-risk HPV strains, the vaccine effectively prevents infections that may otherwise progress to...

0 Yorumlar 0 hisse senetleri 1K Views 0 önizleme

Please log in to like, share and comment!